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Summary
Objective: To explore whether longitudinal change in cartilage thickness in femorotibial subregions of knees with radiographic osteoarthritis
(ROA) differs from that in healthy knees.
Methods: 3 T coronal magnetic resonance (MR) images were acquired in 152 women at seven clinical centers at baseline (BL) and 24
months. Knees from 75 women with signs of ROA in either anterioreposterior or Lyon schuss radiographs were compared with those from
77 asymptomatic healthy controls without ROA to identify knees showing greater change in cartilage thickness than expected based on
observations in healthy knees. The femorotibial cartilage thickness was determined in BL and follow-up MR images across ﬁve tibial and three
femoral subregions in the medial/lateral compartment, respectively.
Results: A substantial portion of knees with ROA were classiﬁed as having longitudinal cartilage thinning (28%) or thickening (20%) in at least
one medial femorotibial subregion based on comparisons to longitudinal changes observed in healthy knees; only 5% showed both subre-
gional thinning and thickening across (different) medial subregions at the same time. Whereas the estimated proportion of Kellgren Lawrence
grade (KLG) 3 knees (n¼ 28) with signiﬁcant medial cartilage thinning (46%) was substantially greater than that with cartilage thickening
(18%), the estimated percentages of KLG2 knees (n¼ 30) with signiﬁcant medial thinning (20%) and thickening (23%) were similar.
Conclusion: This exploratory study indicates that OA may not be a one-way-road of cartilage loss. Subregional analysis suggests that,
compared with healthy knees, cartilage changes in ROA may occur in both directions. Medial femorotibial cartilage thickening was observed
as frequently as cartilage thinning in KLG2 knees.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Change in cartilage thickness is an important feature in
characterizing the structural progression of osteoarthritis
(OA)1e3. Recent longitudinal studies of cartilage morphol-
ogy changes in OA using quantitative magnetic resonance
imaging (MRI) have reported varying rates of change
between studies and between subjects, relative to the
underlying measurement error4e14 (reviewed in1,2,15,16).
Moreover, different (sub)regions in the joint have shown
variable average rates of cartilage thickness change, with
some showing signiﬁcant changes over time and some
not6,9,11,17,18. Individual differences in the rate and anatom-
ical location of change may be attributed to factors such as
natural biological variation, differences in disease stage, or
etiology (e.g., malalignment, adjacent meniscus damage).
Animal studies19e23 have shown that early (experimental)
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329swelling) before tissue is lost. In humans, joint space width
(JSW)24 and cartilage thickness25 have been shown to be
greater in subjects with Kellgren Lawrence grade (KLG) 2
radiographic OA (ROA) than in healthy participants, and
a recent MRI-based study showed signiﬁcant increases in
cartilage thickness over time in patients after acute anterior
cruciate ligament injury26, potentially as a sign of early OA.
Additionally studies using registration techniques27,28 have
reported spatial patterns of knee cartilage thickening and
thinning over time in OA subjects. Taken together, these
ﬁndings indicate that during certain ‘‘early’’ phases of the
disease, knee cartilage tissue may undergo regional swell-
ing or matrix hypertrophy, before net cartilage loss occurs in
the more advanced disease stages. As a consequence,
measures of change such as means or medians may be
compromised when studying populations in which some
knees show regional cartilage thinning and others regional
thickening.
The analysis of the distributions of longitudinal cartilage
thickness changes (thinning or thickening) in a large num-
ber of subregions, and in a mixture of OA knees with differ-
ent ROA grades is complex. To explore how the actual
distribution of change may affect summaries of change
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‘‘behavior’’. First, it is necessary to identify a threshold for
separating OA-related changes from ‘‘normal’’ changes
(i.e., aging) and/or from measurement variability. As long
as sources of variation besides disease-related change,
e.g., measurement error, are comparable or can be con-
trolled appropriately, a reference sample distribution from
a healthy control group may be used to identify ROA knees
with signiﬁcant change, i.e., knees in which longitudinal
changes differ signiﬁcantly (in either direction) from the
‘‘normal’’ reference distribution.
In this study we examined healthy knees and knees with
possible to moderate ROA25 over a period of 2 years9 in
order to:
 estimate the proportion of ROA knees with signiﬁcant
change in cartilage thickness (thinning or thickening)
over time,
 characterize the anatomical location of these changes
across the medial and lateral femorotibial
compartments,
 identify whether the proportions of knees with estimated
cartilage thinning or thickening differ with radiographic
disease stage observed at baseline (BL) (KLG2 or 3).Fig. 1. Image showing the femorotibial subregions. A) Inferior view
of the femoral subchondral bone area, with subregions labeled.
B) Posterior view of femorotibial subchondral bone areas (tibia at
the bottom, weight-bearing femur at the top), with subregions
displayed by different grey values. C) Superior view of the tibial
subchondral bone area, with subregions labeled, e.g., in cMF are
ccMF, ecMF, and icMF, while in MT are cMT, eMT, iMT, aMT,
and pMT. Please note that cMT covers 20% of the tibial subchon-
dral bone area and ccMF 33% of the femoral subchondral bone
area, respectively.Methods
This non-interventional, natural history study included 180 women, of
which 152 (age 56.7 8.6 years) completed BL and month 24 visits9,25.
The study, it’s design, the participant characteristics, the reliability of the
MRI methodology, and the mean rate of change in comparison with radiog-
raphy have been previously reported9,25,29. Inclusion criteria for the ROA par-
ticipants were mild to moderate ROA (KLG2 or 3) in the medial femorotibial
compartment in conventional weight-bearing, extended anterioreposterior
(AP) radiographs, medial disease as demonstrated by medial femorotibial
compartment minimum JSW (mJSW) lateral compartment mJSW, a medial
tibiofemoral JSW of 2 mm in Lyon Schuss (LS) radiographs24,30, and
a body mass index (BMI) of 30. Healthy control participants had to show
a complete absence of symptoms, no sign of radiographic knee OA
(KLG0) in the AP radiographs for either knee, and a BMI 289,25,29. The
study was conducted in compliance with the ethical principles derived from
the Declaration of Helsinki, the local Institutional Review Board, informed
consent regulations, and International Conference on Harmonization Good
Clinical Practices Guidelines.
The subjects were imaged at seven clinical centers29. KLG was ﬁrst
scored at the imaging sites using AP radiographs and then reassessed by
a single experienced reader. If the ﬁrst two readers disagreed, the KLG
was adjudicated by a third reader; reproducibility metrics have been pub-
lished29. The adjudicated AP radiographs led to 90 participants having their
target knee classiﬁed as KLG0, 4 KLG1, 30 KLG2, and 28 KLG3. The LS
radiographs24,30 were also separately read by two experienced readers,
and adjudicated by a third reader and led to 78 participants having their
target knee classiﬁed as KLG0, 7 KLG1, 30 KLG2, and 37 KLG3.
To optimize the approach it was critical that the healthy control knees
were free of disease; therefore the 77 target knees with KLG0 on both the
AP and LS radiographs were considered the ‘‘healthy reference group’’.
Measured differences between visits in this group were expected to be
related to either measurement error or natural biological variation over
time. The remaining 75 knees were KLG> 0 in at least one radiograph
and a disease status ranged from possible ROA (KLG1) and no symptoms
to deﬁnite ROA with symptoms. Most subjects in this group (n¼ 70) were
KLG2 or 3 in at least one radiograph, whereas ﬁve knees were KLG1. The
full group of 75 subjects will be denoted as KLG> 0.
MRI was performed using 3 T magnets9,25,29. Previously validated31e33
double oblique coronal MRI acquisitions were obtained at BL and 24
months, using water excitation spoiled gradient echo sequences at
a 1.0 mm 0.31 mm 0.31 mm3 resolution9,25,29. Segmentation of the
femorotibial cartilages (medial tibia¼MT, lateral tibia¼ LT, weight-bearing
medial femoral condyle¼ cMF, and weight-bearing lateral femoral
condyle¼ cLF) was performed by seven technicians with more than 3 years
experience each in cartilage segmentation, using dedicated software
(Chondrometrics GmbH, Ainring, Germany)9,25,29. The images were read
in pairs (24 months vs BL) with readers blinded to the order of acquisition.
Quality control of all segmentations was performed by one reader (F.E.).
The mean cartilage thickness over the total area of subchondral bone
(ThCtAB)9,25,29,34 was computed for total femorotibial cartilage plates (MT,cMF, LT and cLF), for ﬁve tibial subregions (central, external, internal, ante-
rior, and posterior35 are cMT, eMT, iMT, aMT, and pMT for MT with similar
construction for LT) and for three femoral subregions (central, external, inter-
nal35, are ccMF, ecMF, icMF for cMF with similar construction for cLF) in the
medial and lateral compartment, respectively9,25 (Fig. 1). The central tibial
subregions (cMT, cLT) occupied 20% of the tibial subchondral bone area,
and the central femoral subregions (ccMF and ccLF) 33% of the femoral sub-
chondral bone area35. Precision errors (testeretest with repositioning) for
cartilage thickness in plates ranged from 1.8% to 2.3%33 and those in fem-
orotibial subregions from 1.5% to 4.7%35. Annualized rates of change in
thickness (ThCtAB) were measured over 24 months for compartments
(MFTC¼ cMFþMT, LFTC¼ cLFþ LT, cMFTC¼ ccMFþ cMT, cLFTC¼
ccLFþ cLT), femoral and tibial plates (cMF, MT, cLF, LT), the six subregions
of the femoral plates (three medial, three lateral), and the 10 subregions of
the tibial plates (ﬁve medial, ﬁve lateral)9,25,35.
Cartilage thinning in a subregion was deﬁned as a larger decrease in
ThCtAB than expected relative to the distribution of observed changes for
that subregion in the healthy reference group, whereas cartilage thickening
in a subregion was deﬁned as a larger increase in ThCtAB than expected.
To classify a subject’s subregions according to these deﬁnitions, normalized
values (z-scores) were generated for the reference knees (n¼ 77) and for
the KLG> 0 knees (n¼ 75) for each of the cartilage subregions mentioned
above, by subtracting the mean and dividing by the standard deviation
(SD) estimates from the healthy reference group. Normality plots indicated
that the annualized rates of change in ThCtAB for the reference group
were normally distributed; hence the normalized values were translated to
P values assuming the z-scores were from the normal distribution. These
P values were used to determine whether a subregion in a given subject
showed signiﬁcant cartilage change compared with the healthy reference
group.
Adjustments for multiple comparisons were made using false discovery
rate (FDR) methods with a¼ 0.136. Testing (for thinning and thickening sep-
arately) was done for all subjects and subregions (a total of 7296 tests).
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whether test was for thinning or thickening. This resulted in a total of 96
groups with either 77 or 75 comparisons in each depending on whether
group included healthy or ROA knees, respectively.
Initially, a subject was classiﬁed as having signiﬁcant change (thinning or
thickening) if any compartment (MFTC, LFTC), plate (MT, cMF, LT, cLF) or
subregion P value indicated signiﬁcant change. However, when the deﬁnition
of signiﬁcant change was modiﬁed to include only the cartilage subregions,
only one KLG> 0 participant needed to be reclassiﬁed, so that the results
presented below will use only the latter approach.
The FDR for change in a subject was 0.1 and followed directly from
basic rules of probability and the deﬁnition of change applied here (if one
subregion indicated change, then the knee was assumed to show change).
For a subject to be incorrectly identiﬁed as having change, all subregions
with signiﬁcant change must be incorrect, but the probability of all subregions
showing change being incorrect is less than the probability of a single sub-
region with observed change being a false positive, i.e., 0.1, with equality
holding if all subregions are perfectly correlated.
With this approach, it is possible for the same subject to have subregions
classiﬁed as having cartilage thinning and thickening (albeit in different sub-
regions). KLG> 0 participants not showing cartilage thinning or thickening
(in any subregion) were classiﬁed as ‘‘non-changers’’.
Summary statistics of the frequency and magnitude of estimated cartilage
thinning and thickening were broken down by KLG> 0 subjects and healthy
reference group, speciﬁc KLG (AP or LS radiography), and anatomical
subregions. Odds ratios and Fisher exact tests were used to assess whether
signiﬁcant cartilage change occurred more frequently in KLG3 than in KLG2
participants.
Given the challenges of segmenting diseased cartilage, there was con-
cern that measurement error may be larger in ROA knees compared to
the reference knees, potentially causing the reference sample SD to under-
estimate the appropriate SD for the ROA subjects. Data from testeretest
studies32,37 and a 3 month longitudinal study29 were used to compare
repeatability in healthy and ROA knees. Estimates of measurement error
based on 3 month vs BL data may be confounded with real change, so these
estimates were viewed as upper bounds. Although the SD of change at 3
months was somewhat larger for KLG3 (but not for KLG2) in the femoral
plates29, there was no clear indication that measurement error was generally
larger in ROA participants compared to healthy knees in the previously
mentioned testeretest studies in this sample (only 6.6% P> 0.2). The pri-
mary results reported here will thus use the reference cohort SD to compute
z-scores, but in order to gauge the effect of uncertainty in the relative mag-
nitude of measurement error, a sensitivity analysis was carried out by inﬂat-
ing the reference group SD by up to a) 30% for all KLG> 0 knees, b) 40% for
KLG3 knees, and c) 40% in femoral compartments of KLG3 knees. Discus-
sion of measurement error and the magnitude chosen for these adjustment
factors used in sensitivity analysis can be found in the Supplementary
materials.Results
Of the 70 subjects with deﬁnite ROA in either the LS or
AP views (KLG> 2), 20 (29%) and 14 (20%) were classiﬁed
as having cartilage thinning and thickening in the medial
compartment, while 13 (19%) and six (9%) displayed thin-
ning and thickening in the lateral compartment, respec-
tively. Two of the ﬁve subjects with KLG1 showed
thickening in lateral compartment and one of these also
showed thinning in the medial compartment.Table
Frequency of number of thinning or thickening regions per subjec
Medial compartment
Number of thinning
subregions
Number of thickening subregions N
0 1 2 Total
0 43 10 1 54
1 9 2 0 11
2 0 2 0 2
3 4 0 0 4
4 1 0 0 1
5 2 0 0 2
6 1 0 0 1
Total 60 14 1 75Generally, cartilage thinning or thickening in an individual
were localized and not found in more than two subregions
(Table I). Four knees showed cartilage thickening and thin-
ning ‘‘at the same time’’ (but in different subregions) within
the medial compartment, and two knees within the lateral
compartment. Amongst knees with signiﬁcant change in
the medial and lateral femorotibial compartments, six had
thinning in both compartments, four had thickening in both
compartments, one had thinning in the medial and thicken-
ing in the lateral compartment, and ﬁve had thickening in
the medial and thinning in the lateral compartment. Alto-
gether 37 of 75 KLG> 0 knees were classiﬁed as having
signiﬁcant change (thickening or thinning) in either the
medial or lateral compartment.
In the MT of KLG> 0 knees with cartilage thinning, eMT
was the most frequently involved subregion (71%), followed
by cMT and aMT (29%) each (Table III). Cartilage thicken-
ing was most frequently found in aMT (27% of those with
medial thickening). In cMF, cartilage thinning was most fre-
quently observed in ccMF (38%) and thickening most fre-
quently in ecMF (60%). The lateral compartment showed
a more uniform distribution across all subregions. In the
LT, thinning was most frequently observed in cLT, iLT and
pLT (33% each) and thickening in aLT (33%). In the lateral
femur, thinning was most frequently observed in ccLF and
ecLF (20% each), and thickening in ecLF (50%) (Table II).
When averaged across KLG> 0 participants with
thinning or thickening in any of the medial subregions, the
percent rate of cartilage thinning for MT was highest in
eMT (6.2%) and cMT (3.6%), and for cMF it was highest
in ecMF (4.6%) and ccMF (4.5%) (Table III). Subjects
with cartilage thickening had the most prominent change
in aMT (þ1.8%) and ecMF (þ4.0%). In comparison, the
healthy reference group had changes ranging from 0.6%
to þ0.2%. The lateral subregions (Table IV) showed smaller
decreases in ThCtAB in the group with thinning (up to
4.0%; cLT), but larger increases in the group with thicken-
ing (up to þ7.4%; ecLF). Percent changes in the lateral sub-
regions of the healthy reference group ranged from 0.75%
to 0.3% (Table IV).
Subregion means and SDs for the healthy reference
group and the KLG> 0 non-changers subgroup were simi-
lar. On average the SD of the KLG> 0 subgroup of non-
changers was slightly less (4%) than the SD of the healthy
group and ranged from 20% less to 10% more than the SD
of the healthy reference group.
When SDs used to compute z-scores were adjusted for
potentially larger precision errors in ROA knees, the propor-
tion of subject-regions that continued to be classiﬁed as
having thinning ranged between 0.6 and 0.96 dependingI
t for OA subjects in both medial and lateral compartments
Lateral compartment
umber of thinning
subregions
Number of thickening subregions
0 1 2 Total
0 56 3 1 60
1 8 2 0 10
2 3 0 0 3
3 1 0 0 1
4 1 0 0 1
5 0 0 0 0
6 0 0 0 0
Total 69 5 1 75
Table II
Percentage of subjects with thinning (thickening) in stated region
amongst subjects demonstrating thinning (thickening)
Subregion % With
thinning
% With
thickening
Subregion % With
thinning
% With
thickening
MFTC 33.3 26.7 LFTC 20.0 16.7
cMFTC 38.1 6.7 cLFTC 60.0 0.0
MT 19.0 13.3 LT 26.7 0.0
cMF 28.6 6.7 cLF 13.3 16.7
cMT 28.6 0.0 cLF 33.3 0.0
eMT 71.4 0.0 eLT 6.7 0.0
iMT 14.3 0.0 iLT 33.3 0.0
aMT 28.6 26.7 aLT 0.0 33.3
pMT 0.0 13.3 pLT 33.3 0.0
ccMF 38.1 6.7 ccLF 20.0 0.0
ecMF 28.6 60.0 ecLF 20.0 50.0
icMF 14.3 0.0 icLF 6.7 33.3
The frequency is presented as the percent of subjects that were
identiﬁed to have thinning or thickening in the medial or lateral
compartment. Please note that percentages do no sum to 100%
as some subjects have signiﬁcant changes in multiple measures
and/or subregions.
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thickening was somewhat lower, ranging between 0.47
and 0.91, except for the extreme case where an adjustment
factor of 1.3 was used for all KLG> 0 knees
(proportion¼ 0.20).
The percentage of KLG3 participants with thinning was
much larger (46%) than that of KLG2 participants (20%)
(Table V). The odds of a subject displaying thinning
compared to no thinning was 3.5 or 5.5 times greater for
KLG3 than for KLG2, when using the AP or LS radiographs,
respectively (P< 0.05, Fisher exact test). The odds ratio
ranged from 2.5 to 7.7 when using different SDs to compute
z-scores in order to account for potential differences in pre-
cision error between ROA and healthy knees (Table VI),
and statistical signiﬁcance held for most scenarios.
The percentage of KLG2 participants with thickening
(23%) was about the same as KLG3 participants (18%)
(Table V). The odds of a subject having thickening
compared to no thickening was 0.71 or 0.36 times greater
for KLG3 than for KLG2 when using the AP or LS radio-
graphs (P> 0.1). When an adjusted SD was applied toTable I
Percent annualized rate of change and SD in medial compartment, plates
subgroups is 100 rate of change/healthy group at BL. Healthy reference
relates to subjects that did not have rates of chang
N Healthy group ROA no c
77 43
Region Mean@BL Mean Std dev Mean
MFTC 3.27 0.24 1.23 0.11
cMFTC 4.21 0.41 1.51 0.28
MT 1.58 0.32 1.27 0.34
cMF 1.69 0.17 1.84 0.10
cMT 2.18 0.60 1.82 0.37
eMT 1.38 0.30 1.96 0.51
iMT 1.72 0.06 1.77 0.22
aMT 1.37 0.58 2.00 0.19
pMT 1.36 0.01 1.85 0.41
ccMF 2.04 0.22 2.32 0.18
ecMF 1.26 0.17 2.00 0.39
icMF 1.80 0.35 2.14 0.14the subjects in the ROA group, the odds ratio was close
to one when using the AP radiograph classiﬁcation;
however, the odds ratio was considerably less than 1
when an adjusted SD was used only in KLG3 knees by
either radiograph (P< 0.05, Fisher exact test) (Table VI).
The odds ratio comparing thinning to thickening for KLG3
and KLG2 conﬁrmed the general trend seen from the previ-
ous comparisons. The ratio of subjects with thinning to
thickening was 3e7.6 times higher in KLG3 compared to
KLG2, depending on radiographs (AP or LS) used for clas-
siﬁcation (P< 0.05 for LS radiograph classiﬁcation and for
the subset of subjects where AP and LS classiﬁcations
agree). This odds ratio generally increased as different
adjusted SDs were used to compute z-scores; signiﬁcant
differences between KLG3 and KLG2 were consistently
seen when the LS radiographs were used for classiﬁcation
and P values were nearly as signiﬁcant when analysis was
limited to subjects with AP and LS radiograph classiﬁca-
tions that agreed (P< 0.15 in ﬁve cases, with P< 0.05 for
three cases).Discussion
In this exploratory study we examined the change in
regional femorotibial cartilage thickness of healthy knees
over 2 years to estimate ‘‘normal’’ change over time. This
distribution was used to classify whether participants with
possible to moderate ROA had changes that signiﬁcantly
differed from ‘‘normal’’. A substantial percentage of
KLG> 0 knees were classiﬁed as having more cartilage
thinning (40%) or thickening (21%) over time in at least
one femorotibial subregion compared to the distribution of
change in asymptomatic knees without ROA, which is con-
siderably higher than the percentage expected (1.6%) if the
ROA subjects had no real change. Additionally, if no real
change occurred there is less than a 10% chance that
more than 7% of the ROA subjects would show signiﬁcant
change. Of the 77 healthy reference knees, two (2.6%)
were classiﬁed as having cartilage thinning and two
(2.6%) thickening in the medial compartment, while four
(5.2%) and one (1.3%) were classiﬁed as having thinning
and thickening, respectively, in the lateral compartment.
This closely matches theoretical expectations for false pos-
itives in a healthy population. Hence, both the theoreticalII
, and subregions for different groups. Percent rate of change for all
group are all subjects with AP and LS KL scores¼ 0. ‘‘No change’’
e indicating significant thinning or thickening
hange ROA thinners ROA thickeners
21 15
Std dev Mean Std dev Mean Std dev
1.09 3.11 3.63 1.12 1.88
1.47 4.03 4.57 0.74 2.22
1.14 2.71 2.26 0.96 1.61
1.49 3.48 5.75 1.28 3.04
1.49 3.58 4.21 0.81 1.81
1.83 6.19 5.36 0.91 3.71
1.83 1.71 2.28 0.08 2.52
2.08 2.10 4.10 1.84 2.84
2.02 0.56 1.87 1.12 2.53
2.37 4.51 6.91 0.66 4.31
2.01 4.59 9.96 4.01 2.93
2.00 1.71 3.83 0.14 3.64
Table IV
Percent annualized rate of change and SD in lateral compartment, plates, and subregions for different groups. Percent rate of change for all
subgroups is 100 rate of change/healthy group at BL. Healthy reference group are all subjects with AP and LS KL scores¼ 0. ‘‘No change’’
relates to subjects that did not have rates of change indicating significant thinning or thickening
N Healthy group ROA no change ROA thinners ROA thickeners
77 56 15 6
Region Mean@BL Mean Std dev Mean Std dev Mean Std dev Mean Std dev
LFTC 3.61 0.08 1.10 0.17 1.12 1.71 2.17 1.71 1.64
cLFTC 4.99 0.02 1.35 0.19 1.37 2.99 3.97 0.51 2.28
LT 1.96 0.37 1.31 0.27 1.25 2.38 2.39 0.26 1.24
cLF 1.65 0.28 1.98 0.68 1.75 0.92 2.95 4.05 2.72
cLT 3.01 0.16 1.86 0.13 1.91 4.03 4.80 0.52 0.99
eLT 1.57 0.27 1.82 0.12 1.99 0.79 2.99 0.98 2.07
iLT 1.89 0.20 1.76 0.35 1.90 2.19 3.58 0.52 1.85
aLT 1.57 0.65 2.34 0.26 2.07 0.43 2.89 2.28 4.44
pLT 1.84 0.73 2.48 0.69 2.06 3.84 4.32 2.34 4.54
ccLF 1.98 0.20 2.33 0.68 2.06 1.40 4.36 2.08 5.35
ecLF 1.45 0.32 2.48 1.11 2.23 0.44 5.12 7.39 3.52
icLF 1.57 0.32 2.15 0.30 2.37 0.75 2.87 3.30 3.71
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KLG> 0 subjects with thinning or thickening is unlikely
due to chance.
The classiﬁcation of participants as having thinning, thick-
ening, or no change is highly dependent on the classiﬁca-
tion methods used. Key steps in the method that play
a large role are the deﬁnition of thinning and thickening;
the use of FDR, in particular the choice of a¼ 0.1; and
the choice of comparison distribution, especially the role
of measurement error and other sources of variability.
Therefore, these classiﬁcation results are only estimates
of the percent of subjects with change for this cohort. Given
the limited number of knees, the many cartilage subregions
investigated, and potential impact of differences in mea-
surement error between ROA and healthy knees, these re-
sults should be considered preliminary and must be tested
in a much larger cohort.
While many KLG> 0 knees showed evidence of signiﬁ-
cant changes in at least one subregion, the distribution of
changes in KLG> 0 subjects classiﬁed as non-changers
mirrored the distribution of the healthy reference population.
The similarity of these two distributions indicates that small,
but not signiﬁcant, changes do not appear to be widespread
in the KLG> 0 non-changer group. This implies that the
ROA knees may be viewed as a dichotomy: individuals
that undergo real change and those that are in stasis for
extended periods. While this is probably not surprising,Table V
Number of subjects (% within KLG) with thinning or thickening by
KL grade
AP KL n Cartilage thinning Cartilage thickening
Medial Lateral Medial Lateral
1 4 0 (0.0) 1 (25.0) 0 (0.0) 0 (0.0)
2 30 6 (20.0) 5 (16.7) 7 (23.3) 1 (3.3)
3 28 13 (46.3) 5 (17.9) 5 (17.9) 3 (10.7)
LS KL
1 7 0 (0.0) 2 (28.6) 1 (14.3) 0 (0.0)
2 30 4 (13.3) 6 (20.0) 9 (30.0) 2 (6.7)
3 37 17 (45.9) 7 (18.9) 5 (13.5) 4 (10.8)
Please note that percentages do no necessarily sum to 100% as
some subjects have signiﬁcant thickening and thinning in one or
more compartments.the principle is easily overlooked and has important conno-
tations for measuring change in the OA population.
A strength of the study is the relatively large cohort of
healthy control participants available for comparison. While
this study included a relatively small number of participants
with KLG2 or KLG3, tests were signiﬁcant for most hypoth-
eses, e.g., the proportion of thinning subjects or ratio of thin-
ning to thickening in KLG3 compared to KLG2 in the medial
compartment. One potential reason hypotheses were not
signiﬁcant, e.g., the proportion of subjects in KLG3 com-
pared to KLG2, may be lack of power.
Clearly the results reported depend on the choice of
decision rules for signiﬁcant change and the deﬁnition of
subregions. Although different demarcations of subregions
might lead to different results regarding the spatial distribu-
tion of change in cartilage thickness, a recent study of par-
ticipants from the OA Initiative progression cohort reported
no substantial differences in the rates of change and the
standardized response mean18 when the size of the central
subregion was changed. While average results reported
there do not conﬁrm individual behavior, it does show that
effects of minor changes in subregion size and deﬁnitions
would likely be small.
Probably the most sensitive component of the decision
rule is the choice of SD used to compute z-scores, so study-
ing the impact of the decision rule coincides with concerns
about differences in measurement error between ROA and
healthy knees. Not surprisingly, the proportion of subjects
classiﬁed as having signiﬁcant change decreased with
increased SD. However, only when the SD assumed for
all KLG> 0 subjects was 30% larger than healthy SD did
the proportion of participants with thickening decline to
values coinciding with background noise.
As noted previously, KLG3 participants were estimated to
be 3e5 times more likely to have cartilage thinning than
KLG2 participants, but the odds were about the same for
thickening in the two groups. While the signiﬁcance of the
tests declined with increased SD, the odds ratio remained
fairly consistent. So even though the estimated absolute
proportions of signiﬁcant change in subregions and sub-
jects changed when using different SDs to compute
z-scores, the relative proportions between the KLG2 and
KLG3 groups did not.
Interestingly, although the mean change of cartilage
thickness in KLG2 participants did not differ signiﬁcantly
Table VI
Odds ratio for primary analysis and different sensitivity analyses. Odds ratio compare odds between KLG3 and KLG2 groups as classified by
AP or LS radiographs. Odds are either thinning vs no thinning (none), thickening vs no thickening, or thinning vs thickening. Non OA SD for
rate of change is used unless otherwise noted. aKL3¼KLG3, adjustment factor¼ 1.2; aKL3f¼ KLG3 and femoral compartments adjustment
factor¼ 1.4; Adj 1.x¼ all OA subjects with adjustment factor 1.x
Odds ratio Odds Orig aKL3 aKL3f Adj1.1 Adj1.2 Adj1.3
AP KL3/KL2 Thin/none 3.47* 3.47* 2.37 4.21* 4.26* 3.60þ
LS KL3/KL2 Thin/none 5.53* 5.53* 3.12þ 5.48* 6.72* 5.92*
AP KL3/KL2 Thick/none 0.71 0.48 0.31 1.08 1.08 1.07
LS KL3/KL2 Thick/none 0.36 0.24* 0.06* 0.18 0.18 0.81
AP KL3/KL2 Thin/thick 3.03 4.33 5.40 2.75 3.00 2.67
LS KL3/KL2 Thin/thick 7.65* 11.33* 27.00* 18.67* 24.00* 5.50
KL3/KL2 (AP¼ LS) Thin/thick 6.50* 8.67* 18.00* 11.00 18.00 8.00
*P< 0.05, þP< 0.1 (Fisher exact test).
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gion9, the current ﬁndings indicate that the distribution of
change in cartilage thickness may differ substantially from
that in healthy participants. This is in agreement with obser-
vations made in animal studies19e23 that, in ‘‘early’’ OA, car-
tilage may undergo thickening before tissue is lost. Also,
cross-sectional X-ray studies in humans have shown larger
JSW24 and greater cartilage thickness in KLG2 than in
KLG0 or KLG3 participants25. Similarly, longitudinal studies
of anterior cruciate ligament (ACL) injuries26 and studies
that applied registration techniques (thickness mapping) to
OA cohorts27,38 have indicated that cartilage thickening
may occur in the OA process. The current study thus
increases the evidence that cartilage thickening may occur
in certain stages of human OA, predominantly at the
earlier radiographic grades (KLG2). Studies using larger
cohorts, such as the OA Initiative, are needed to provide
further conﬁrmation of these observations. Also, further
studies are needed to identify BL measures that allow one
to classify OA knees that will subsequently encounter
cartilage thickening and thinning. This may potentially
permit novel recruitment strategies for clinical trials in order
to reduce the number of knees needed when testing a dis-
ease modifying OA drug (DMOAD). Also, proper ‘‘a priori’’
classiﬁcation may allow one to test DMOADs that selec-
tively target cartilage thickening (swelling or hypertrophy)
or thinning (loss).
The current ﬁndings may help explain why the sensitivity
to change of cartilage morphology measurements in this9
and other studies have been relatively unsatisfactory.
When studying populations in which some participants un-
dergo cartilage thinning and others cartilage thickening, es-
timates of change such as the mean are seriously
compromised9 because subgroups may cancel each other
out when averaging over all subjects. Hence cartilage mor-
phology may be observed to have no signiﬁcant change9,
while in fact signiﬁcant changes are present, albeit in differ-
ent directions in different subjects.
In conclusion, the results of subregional analysis in this
study suggests that, compared with healthy knees, cartilage
changes in ROA may occur in both directions: knees clas-
siﬁed with medial femorotibial cartilage thickening were ob-
served as frequently as medial thinning was in KLG2 knees,
whereas among KLG3 knees cartilage thinning was 2.6
times more frequent than cartilage thickening. Although
sensitivity analyses indicated that these estimates are
robust for slight increases in measurement errors in ROA
knees, the conclusions in this paper depend on the
assumption that the causes and magnitude of variability in
ROA knees not directly related to disease are equivalent
to those in healthy subjects. If these underlying sources ofvariability differ (e.g., due to substantial differences in mea-
surement error) the results may be biased. Given that the
original study was not designed to address this question
directly, the current results should be viewed as exploratory
and need to be conﬁrmed in larger cohorts.Conﬂict of interest
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